[DOI] [PubMed] [Google Scholar] 71.Wright A.K., Carr M.J., Kontopantelis E., Leelarathna L., Thabit H., Emsley R., Buchan I., Mamas M.A., Van Staa T.P., Sattar N., et al
To view a copy of this licence, visit About this article Cite this article Tavakoli, A., Akhgarjand, C., Ansar, H
PT-141 Safety Profile PT-141's safety profile is the best characterized of any melanocortin peptide in humans, because it is the only one to have completed Phase III trials
B12 injections are most clearly indicated when: A person has confirmed B12 deficiency that requires rapid replacement Theres a known or likely absorption issue Theres a need for ongoing maintenance due to non-dietary causes (for example, autoimmune gastritis) Typical treatment schedules (UK guidance) Treatment schedules can vary depending on symptoms, severity, and cause
199,201 Decreased oxygenation in the cochlea may be a potential cause of sudden sensorineural hearing loss